SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-016749
Filing Date
2020-07-06
Accepted
2020-07-06 16:43:58
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_inspyrtherapeutics.htm 10-Q 574474
2 CERTIFICATION f10q0320ex31-1_inspyr.htm EX-31.1 7193
3 CERTIFICATION f10q0320ex31-2_inspyr.htm EX-31.2 7396
4 CERTIFICATION f10q0320ex32-1_inspyr.htm EX-32.1 4720
5 CERTIFICATION f10q0320ex32-2_inspyr.htm EX-32.2 4755
  Complete submission text file 0001213900-20-016749.txt   2285134

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20200331.xml EX-101.INS 265740
7 XBRL SCHEMA FILE nspx-20200331.xsd EX-101.SCH 32470
8 XBRL CALCULATION FILE nspx-20200331_cal.xml EX-101.CAL 31661
9 XBRL DEFINITION FILE nspx-20200331_def.xml EX-101.DEF 104610
10 XBRL LABEL FILE nspx-20200331_lab.xml EX-101.LAB 205609
11 XBRL PRESENTATION FILE nspx-20200331_pre.xml EX-101.PRE 156073
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 201013962
SIC: 2834 Pharmaceutical Preparations